Joint Transnational Call for Proposals (2026) for Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
The European Partnership for Personalised Medicine, EP PerMed (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129), is a platform for joint programming of national and European regional research and innovation supporting activities putting into action “The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (2023)”, SRIA for PM (2023), through dedicated research, development and innovation funding.
The EP PerMed funding organisations listed below have agreed to launch the joint transnational call 2026 (JTC2026) “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acronym: CARMEN2026), co-funded by the European Union, to fund multinational, innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe and beyond in this field. The JTC2026 will be conducted simultaneously by the participating funding organisations in their respective region/country and coordinated centrally by the Joint Call Secretariat (JCS), hosted by the French National Research Agency, (ANR), FRANCE.
The call will be implemented in two stages, i.e. a pre- and a full proposal phase. The available budget for this call is 38 Mio. € (approx.).
Expected timeline of the call
|
25 November, 2025 |
Publication of the call |
|
16 December, 2025 |
JTC2026-Information Day online webinar : Register here |
|
26 January 2026, 23:00, CET) |
Deadline to complete the SAMRC Pre-eligibility Check form. |
|
10 February, 2026 (14:00, CET) |
Deadline for pre-proposal submission to PT OUTLINE |
|
Expected around 05 May, 2026 |
Communication of the results of the pre-proposal assessment and invitation to the full proposal stage |
|
09 June, 2026 (14:00, CEST) |
Deadline for full proposal submission |
|
Mid/end of August 2026 |
Rebuttal stage |
|
Expected for October 2026 |
Communication of the funding decisions to the applicants |
|
End of 2026, beginning of 2027 |
Expected project start (according to regional/national funding regulations) |
Information Day
An information day introducing the JTC2026 to the research community will be organised on 16 December 2025, 10:00 AM CET.
For more information and accessing the registration form: https://www.eppermed.eu/news-events/events/ep-permed-jtc2026-information-day/
Electronic submission website
Electronic proposal submission is mandatory on PT-Outline. Research project consortia who intend to submit a transnational proposal should register as soon as possible, by clicking on “Sign up” and follow further instructions.
Contact persons for the Joint Call Secretariat (JCS)
The EP PerMed JCS is hosted by the French National Research Agency (ANR), France:
Monika Frenzel
Phone: +33 01 73 54 83 32
Email: eppermed@agencerecherche.fr
EP PerMed Partnering Tool
The new partnering tool https://www.b2match.com/e/eppermed-partnering will open soon.
Call Documents
Depending on the country of origin, additional documents may be required:
All South African Applicants must complete the pre-eligibility check before submission of the joint application. This SAMRC Pre-eligibility Check form must be completed by South African Applicants.
Deadline to complete the SAMRC Pre-eligibility Check form is 26 January 2026.
The call text and all additional documents can be downloaded below:
- Call Announcement (PDF)
- Call text (PDF)
- Guidelines for applicants (PDF)
- Pre-proposal form (DOCX)
- Full-Proposal Form (DocX)